RecruitingPhase 1NCT06692426

Trial of Cell Based Therapy for DMD

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Masonic Cancer Center, University of Minnesota
Principal Investigator
Peter Kang, MD
Intervention
MyoPAXon(drug)
Enrollment
8 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06692426 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy

← Back to all trials